Victory Capital Management Inc Intellia Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 12,654 shares of NTLA stock, worth $129,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,654

Previous 12,225 3.51%

Holding current value

$129,070

Previous $273,000 4.76%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$19.72 - $27.36 $8,459 - $11,737	429 Added 3.51%	12,654 $260,000
Q2 2024 Aug 05, 2024	SELL	$20.02 - $27.22 $3,483 - $4,736	-174 Reduced 1.4%	12,225 $273,000
Q1 2024 May 03, 2024	BUY	$23.82 - $32.8 $13,505 - $18,597	567 Added 4.79%	12,399 $341,000
Q4 2023 Feb 05, 2024	SELL	$23.16 - $32.34 $358,609 - $500,752	-15,484 Reduced 56.68%	11,832 $360,000
Q3 2023 Nov 06, 2023	BUY	$31.62 - $45.78 $14,861 - $21,516	470 Added 1.75%	27,316 $863,000
Q2 2023 Jul 27, 2023	SELL	$34.58 - $46.03 $7,261 - $9,666	-210 Reduced 0.78%	26,846 $1.09 Million
Q1 2023 May 02, 2023	BUY	$33.3 - $44.82 $58,641 - $78,928	1,761 Added 6.96%	27,056 $1.01 Million
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $2,656 - $5,015	80 Added 0.32%	25,295 $882,000
Q4 2022 Feb 09, 2023	SELL	$33.21 - $62.69 $20,357 - $38,428	-613 Reduced 2.37%	25,215 $879,000
Q3 2022 Nov 02, 2022	SELL	$53.92 - $71.7 $131,403 - $174,732	-2,437 Reduced 8.62%	25,828 $1.45 Million
Q2 2022 Aug 01, 2022	SELL	$38.49 - $76.21 $21.5 Million - $42.7 Million	-559,666 Reduced 95.19%	28,265 $1.46 Million
Q1 2022 May 04, 2022	SELL	$58.27 - $118.99 $2.31 Million - $4.71 Million	-39,566 Reduced 6.31%	587,931 $42 Million
Q4 2021 Feb 07, 2022	SELL	$100.76 - $138.36 $14.3 Million - $19.6 Million	-141,959 Reduced 18.45%	627,497 $74.2 Million
Q3 2021 Nov 02, 2021	BUY	$132.37 - $176.78 $49.8 Million - $66.5 Million	375,933 Added 95.53%	769,456 $103 Million
Q2 2021 Aug 03, 2021	BUY	$60.88 - $161.91 $21.5 Million - $57.2 Million	353,428 Added 881.48%	393,523 $63.7 Million
Q1 2021 May 04, 2021	BUY	$46.59 - $83.68 $209,794 - $376,811	4,503 Added 12.65%	40,095 $3.22 Million
Q4 2020 Feb 01, 2021	SELL	$18.83 - $63.53 $33,762 - $113,909	-1,793 Reduced 4.8%	35,592 $1.94 Million
Q3 2020 Nov 09, 2020	BUY	$17.47 - $24.93 $653,115 - $932,008	37,385 New	37,385 $743,000
Q2 2020 Aug 07, 2020	SELL	$11.14 - $22.87 $60,412 - $124,024	-5,423 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$9.44 - $15.58 $29,179 - $48,157	-3,091 Reduced 36.3%	5,423 $66,000
Q4 2019 Feb 06, 2020	BUY	$10.43 - $17.67 $32,791 - $55,554	3,144 Added 58.55%	8,514 $125,000
Q4 2019 Feb 04, 2020	BUY	$10.43 - $17.67 $3,640 - $6,166	349 Added 6.95%	5,370 $64,000
Q3 2019 Nov 12, 2019	BUY	$13.07 - $18.51 $65,624 - $92,938	5,021 New	5,021 $67,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Intellia Therapeutics, Inc. Transaction History